DNMT3A and leukemia: Also, Nicholas et al. found that long-term treatment of leukemia cells with dasatinib and 5-AZA strongly attenuated proliferation of these cells through upregulation of miR-217 and suppression of DNMT3A expression in vitro (Nishioka et al., 2014).